Table 4 Univariate and multivariate analysis of 3-years MACE in patients with end stage renal disease who received CTO PCI.
From: Revascularization of coronary chronic total occlusion in patients with end stage renal disease
Univariate analysis | P value | Multivariate analysis | P value | |
|---|---|---|---|---|
Success vs. fail | 0.518 (0.332–0.810) | 0.004 | 0.588 (0.369–0.939) | 0.026 |
Age | 1.026 (1.008–1.045) | 0.004 | 1.032 (1.012–1.052) | 0.002 |
Gender | 0.685 (0.419–1.119) | 0.131 | 1.015 (0.590–1.745) | 0.957 |
Hb | 0.875 (0.767–0.998) | 0.047 | 0.889 (0.781–1.013) | 0.077 |
Prior stroke | 0.655 (0.328–1.306) | 0.229 | ||
PAD | 2.369 (1.469–3.821) | 0.001 | 2.353 (1.381–4.010) | 0.002 |
HT | 1.000 (0.531–1.882) | 1.000 | ||
DM | 1.889 (1.180–3.024) | 0.008 | 1.852 (1.132–3.030) | 0.014 |
Hyperlipidemia | 0.910 (0.584–1.416) | 0.675 | ||
AF | 1.372 (0.645–2.915) | 0.411 | ||
Prior CABG | 0.748 (0.346–1.621) | 0.462 | ||
HF | 1.494 (0.980–2.278) | 0.062 | ||
Beta blocker | 0.632 (0.399–1.000) | 0.050 | 0.782 (0.481–1.273) | 0.323 |
ARB | 0.829 (0.488–1.408) | 0.487 | ||
Statin | 0.548 (0.323–0.931) | 0.026 | 0.539 (0.309–0.939) | 0.029 |
